To our knowledge, this is one of the few studies examining the association of OPRM1 (rs1799971; rs510769) and OPRD1 (rs2236861) polymorphisms with pain severity, opioid efficacy, and adverse drug reactions specifically in colorectal cancer patients from Latin America. This evidence concerns the gene OPRM1 and colorectal cancer.